Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 20 results found. Search for [ remdesivir injection price ]

Results 1 to 20 of 20
PB Jayakumar
May 3, 2021
Demand fell to almost nil by January after the first wave of the pandemic in the country. Since there was no demand, most manufacturers stopped giving fresh orders for manufacturing


PTI
April 30, 2021
A bench headed by Justice D Y Chandrachud was informed that there is a growing demand from some quarters to permit the use of Remdesivir even when a person is taking treatment at his own home under his own private medical supervision


BusinessToday.In
April 30, 2021
Gilead will dispatch 75,000 to 1,00,00 vials in the next one or two days. Further, 100,000 will also be supplied before or by May 15. EVA Pharma will supply 10,000 vials initially, followed by 50,000 every 15 days or till July


BusinessToday.In
April 21, 2021
This customs duty waiver will remain in effect till October 31, 2021, and is among the measures to increase the production and supply of the anti-COVID-19 drug as infections rise rapidly


BusinessToday.In
April 17, 2021
The National Pharmaceutical Pricing Authority under the Department of Pharmaceuticals declared change in prices for seven brands of Remdesivir injections of potency 100mg per vial


India Today Tech
New Delhi, April 16, 2021
Some websites and helpline numbers are assisting patients, and people in need get more information about hospital beds, Remdesivir injections and oxygen cylinders.


Rai Vinaykumar
April 14, 2021
Fast-track approval has been given for seven additional sites having production capacity of 10 lakh vials/month. Another 30 lakh vials/month production is lined up.


BusinessToday.In
April 9, 2021
Mumbai Police's crime branch nabbed a person with 12 Remdesivir vials on Thursday. Following this, several late-night raids were carried out, during which the cops seized more than 272 Remdesivir injections from one GR Pharma shop


BusinessToday.In
March 25, 2021
Shares of Craftsman Automation, Anupam Rasayan, Laxmi Organic Industries, Adani Green, Cadila, TVS Motors, Bank of India, Jubilant FoodWorks will be in focus in Thursday's trading session


BusinessToday.In
March 24, 2021
This move to further revise the prices will go a long way in helping patients during these critical times, the company said.


BusinessToday.In
March 24, 2021
Stock Market News Update Today: The BSE Sensex witnessed broader-based selling with 28 out of 30 BSE index heavyweights ending in red amid fear that second and third wave infections in India are bound to hamper economic recovery


BusinessToday.In
October 16, 2020
The WHO said that the Solidarity trial looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalised patients


PB Jayakumar
August 13, 2020
Remdesivir price: Zydus is the fifth Indian company to launch the drug for coronavirus treatment after Hetero Labs, Cipla, Mylan NV and Jubilant Life Sciences. Priced at Rs 2,800 for a 100 mg lyophilized injection, its brand 'Remdac' will be the most economical


BusinessToday.In
August 4, 2020
Stocks to watch today on August 4: Yes Bank, Jubilant Life, Exide, Bank of India, Dhanlaxmi Bank among others are the top stocks to watch out for in Tuesday's trading session.


BusinessToday.In
July 20, 2020
Remdesivir is one of the few medicines believed to be effective in treating coronavirus patients. So far, it has secured approvals for emergency use from US FDA and conditional approval from the European Commission.


PTI
July 15, 2020
Covifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitalised with severe symptoms of the disease


PB Jayakumar
July 8, 2020
Various medical shops have been telling buyers that the medicine is in short supply but can be made available If they are ready to pay a premium, DCGI has been informed


BusinessToday.In
July 6, 2020
Mylan has been licensed by Gilead for marketing the drug in 127 low- and middle-income countries, including India. The company will manufacture remdesivir at its injectables facilities in India


PB Jayakumar
June 24, 2020
Remdesivir, allowed for emergency use in COVID-19 patients from May 1, is currently given as an injection and can be used only in hospitals


BusinessToday.In
June 22, 2020
India's Drug Regulator gave permission to Hetero and Cipla to manufacture and market antiviral drug remdesivir for \"restricted emergency use\" on hospitalised COVID-19 patients


PAGES 1 OF 1